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by-products (3). These short chain fatty acids (SCFA*), which In vivo, butyrate is a major energy source for the colonic occur in millimolar amounts, are rapidly absorbed in the epithelium and is thought to stimulate proliferation. In colon, providing important energy supplies for the colorectal contrast, butyrate in vitro has been shown to inhibit epithelium and maintaining the cellular electrolyte balance (4).
proliferation and induce differentiation and apoptosis in
Out of three SCFA, butyrate is considered to be the preferred colonic epithelial cells. Most colon cell cultures are grown energy source and it accounts for~70% of the total energy in medium containing high concentrations of glucose, consumed in rat colonocytes (4,5) and in vivo is reported to whereas in vivo, the main energy source used by the colon stimulate proliferation (6). This stimulation of proliferation is cells is butyrate. The aim of this study was to determine regarded as a physiological response rather than a pre-neowhether the apparent contrasting roles of butyrate in vivo plastic associated phenomenon, since the dividing cells do not and in vitro could be as a consequence of differences in extend to the top of the crypt (7). Conditions which reduce glucose availability. The sensitivity of two human colorectal the concentration of luminal SCFA have been shown to result tumour cell lines, one adenoma (S/RG/C2) and one carcinin decreased epithelial cell proliferation. These conditions oma (HT29) to butyrate-induced growth inhibition and include colonic bypass surgery (8), feeding of a substrate-free apoptosis was investigated to determine whether these diet (9) and germ-free conditions (10). The reduced level of cellular effects were altered under glucose depleted culture SCFA results in metabolic starvation, accompanied by mucosal conditions. Glucose depletion resulted in increased surface degeneration and acute inflammation of the colonic apoptosis in both cell lines in the absence of butyrate.
epithelium (11). Colonic instillation of SCFA has been shown Butyrate in standard culture conditions (containing 25 mM to be beneficial in reducing this inflammation (12) and these glucose and 1 mM pyruvate) inhibited growth and induced studies have concluded that in vivo, butyrate is growth stimulaapoptosis in both cell lines. However, low concentrations tory and beneficial. of butyrate in glucose depleted culture conditions (i.e.
In contrast, butyrate in vitro has been shown to inhibit standard growth medium without glucose and pyruvate proliferation in a number of colorectal tumour cell lines supplements) were found to reduce apoptosis induced by (13, 14) . In addition, treatment of the colon carcinoma cell line glucose deprivation and increase cell yield in both cell lines.
HT29 with butyrate led to a permanently differentiated cell The results show that in glucose depleted culture conditions, line (14). More recently, butyrate, propionate and acetate have butyrate at low concentrations (0.5 mM for S/RG/C2, and been shown to induce apoptosis in a number of colonic tumour 0.5 and 2 mM for HT29 cells) was found to be growth cell lines, with butyrate being the most effective inducer of stimulatory whereas in the presence of glucose, these apoptosis (15-17). These in vitro observations suggest a same concentrations of butyrate induced apoptosis. Thus, possible protective role for short-chain fatty acids in colorectal whether butyrate is growth stimulatory or growth inhibitcarcinogenesis and may explain, in part, the apparent protective ory may depend on the availability of other energy sources.
role of dietary fibre. However, the effects of butyrate on These observations may, in part, provide an explanation proliferation, based on in vivo and in vitro studies, appear to for the apparent opposite effects of butyrate on proliferation
give contradictory results. The preferred energy source for the reported in vivo and in vitro.
colonic epithelium in vivo is butyrate (4,5), whereas most cell cultures are grown in tissue culture medium containing high levels of glucose for their energy source. Hence, differences in energy availability may, in part, provide an explanation for Colorectal cancer is a common malignancy of western society the observation that in vivo butyrate is reported to be growth and this high incidence is thought to be largely associated stimulatory, whereas in vitro it is growth inhibitory. with dietary factors. A low fibre diet was proposed to contribute
In this study, since butyrate is the preferred energy source to an increased risk of colorectal cancer (1), a view supported of the three SCFA present in the colon, we investigated the by more recent epidemiological studies, which have provided effects of butyrate on cell growth and apoptosis under two strong support for this association (2). Carbohydrates which growth conditions: standard culture medium with high concenescape enzymatic digestion in the human small intestine trations of glucose and culture medium without glucose supplementation. We asked whether under glucose-depleted colonic cells to butyrate.
Two human colonic tumour cell lines, an adenoma cell line, S/RG/C2 (18) , and the carcinoma cell line, HT29, were routinely grown on tissue culture plastic in Dulbecco's modified Eagle medium (DMEM; Life Technologies, Inc.) with 20 and 10% fetal bovine serum (batch selected), respectively, as described previously (19) . Cells for the experiments were grown in either normal growth medium (DMEM), which had D(ϩ) glucose (25 mM, Sigma) and sodium pyruvate (1 mM, Gibco BRL), referred to as Glu ϩ Pyr ϩ , or in DMEM medium which did not have added glucose and pyruvate. This was defined as glucose and pyruvate deficient medium referred to as Glu -Pyr -in the text. In these growth conditions, the other main potential energy sources available to the cells are glutamine and amino acids present in the medium and also the fetal bovine serum supplemented to the medium. For the experiments, 1ϫ10 6 human colonic adenoma cell line (S/RG/ C2) and 5ϫ10 5 human colonic carcinoma cell line (HT29) cells were seeded in 25 cm 2 flasks and grown for 3 days in normal fully supplemented medium (Glu ϩ Pyr ϩ ) to achievẽ 50% confluent cultures. At this point, cells were grown in either Glu ϩ Pyr ϩ or Glu -Pyr -medium in the presence of various concentrations (0-10 mM) of sodium butyrate (Sigma). After 4 days growth in the appropriate medium, the attached cells (those remaining adherent to the tissue culture flasks) and floating cells (those having detached from the tissue culture flasks) were counted separately. As described previously, the level of apoptosis in cultured epithelial cell lines was assessed by measuring the proportion of the total cell population that had detached from the cell monolayers and was floating in the medium and determining the fraction of these floating cells that were apoptotic (15, 16, 20, 21) . Apoptotic cells were identified by their characteristically condensed chromatin stained by acridine orange (5 µg/ml in phosphate buffered saline) (15,17). The floating cells have previously been shown to have a high percentage of cells which display classical apoptotic cell morphology (80-90%), while the proportion of apoptotic cells in the attached compartment was low (Ͻ3%) in both control and butyrate treated cultures (15).
Effect of butyrate on growth inhibition
S/RG/C2 cells grown in Glu ϩ Pyr ϩ showed a dose-dependent reduction in attached cell yield with increasing concentrations of butyrate ( Figure 1A ). HT29 cells were also growth inhibited by butyrate (Figure 2A ) and showed an overall reduced sensitivity to butyrate in comparison to that observed in S/RG/C2 cells. To determine whether the growth inhibitory effects of butyrate are altered depending on the level of other potential energy sources present in the colon, we measured the effects of butyrate on cell growth in glucose/pyruvate in a reduction in the attached cell yield compared to the cell yields in Glu ϩ Pyr ϩ media ( Figures 1A,B and 2A,B) . Interestingly, butyrate in Glu -Pyr -growth conditions increased treated with butyrate in Glu ϩ Pyr ϩ growth conditions (Figures cell yield at the lower butyrate concentration of 0.5 mM in 1 and 2). S/RG/C2 ( Figure 1B , P Ͻ 0.05), with a similar effect in HT29 Therefore, to summarize, in the presence of glucose and cells at 0.5 and more significantly at 2 mM butyrate (Figure pyruvate, butyrate is growth inhibitory in both cell lines. 2B, P Ͻ 0.05). Furthermore, both cell lines in Glu -PyrWithdrawal of glucose and pyruvate from the culture medium conditions were also found to be less sensitive to growth (in the absence of butyrate) reduced the attached cell yield in both cell lines, but the presence of butyrate in these glucoseinhibition by butyrate at the higher doses compared to cells tions can be growth stimulatory were also found in two other human colon tumour cell lines (results not shown). Furthermore, the apparent biphasic effect of butyrate with growth stimulation observed at the low concentrations (0.5 and 2 mM) compared to growth inhibition at the higher doses (4-6 mM) may have implications for the role of butyrate in vivo. An intracellular concentration gradient has been suggested to occur along the colonic crypt (22) with higher concentrations at the lumenal surface being growth inhibitory and lower concentrations of butyrate at the base of the crypt being growth stimulatory.
Effects of butyrate on apoptosis
Withdrawal of glucose and pyruvate (without addition of butyrate) from the cultures resulted in an increase of approximately 2-and 3.5-fold in the percentage of floating apoptotic cells in S/RG/C2 and HT29 cells, respectively, compared to cells grown in Glu ϩ Pyr ϩ media ( Figures 3B and 4B) . The presence of butyrate in cultures grown in normal growth conditions (Glu ϩ Pyr ϩ ) increased the percentage of floating apoptotic cells in both cell lines ( Figures 3A and 4A) . However, when cells were treated with butyrate in Glu -Pyr -growth conditions, there was a reduction in the percentage of floating apoptotic cells at the lower butyrate concentrations of 0.5 mM in both cell lines when compared to cells grown in Glu -Pyrmedium without butyrate ( Figures 3B and 4B) . Furthermore, the overall sensitivity of both cell lines to the induction of apoptosis at higher butyrate concentrations relative to controls was also reduced in Glu -Pyr -growth conditions.
One possible explanation for why butyrate is growth stimulatory in vivo is that colonocytes are dependent on the SCFA for their energy supply and metabolize it efficiently. Thus, as well as acting as an energy source in vivo, the efficient metabolism of butyrate may result in reduced intracellular concentration and thus reduces its growth inhibitory properties (23) , whereas in vitro, cells in tissue culture medium with high glucose are adapted to using glucose as their energy source. Under conditions of glucose depletion, there was a reduction in cell yield and an increase in apoptosis in both the adenoma (S/RG/C2) and carcinoma cells (HT29). We then investigated whether the addition of butyrate to cell cultures in glucose depleted medium would enhance growth and reduce apoptosis. We reasoned that these conditions may be more similar to the in vivo situation where the preferred energy source is butyrate, and where glucose, although available through the vasculature, is not the main energy source for colonic epithelium. Interestingly, the addition of butyrate to glucose depleted medium at the lower butyrate concentration did not result in an additive effect in terms of a reduction in attached cell yield or induction of apoptosis. On the contrary, there was evidence of an enhanced cell yield and reduced apoptosis at the lower could be growth inhibitory because less butyrate is being metabolized as an energy source (due to the high levels of glucose), which may result in increased intracellular accumulaand pyruvate-depleted culture conditions did not result in an additive effect in terms of a reduction in attached cell yield.
tion of butyrate ultimately leading to growth inhibition, differentiation and apoptosis. Increased intracellular accumulaOn the contrary, there was evidence of an enhanced cell yield at the lower butyrate concentrations in both cell lines in tion of butyrate may lead to histone hyperacetylation which is one possible mechanism by which butyrate is thought to exert Glu -Pyr -growth conditions (0.5 mM in S/RG/C2 and 0.5 and 2 mM butyrate in HT29 cells). These observations that low its growth inhibitory properties (reviewed in 24). However, when the energy availability is limiting for a particular tissue concentrations of butyrate in glucose-depleted culture condi- Glu -Pyr -medium than in Glu ϩ Pyr ϩ medium (results not in vivo or cell culture, butyrate may be used as an energy shown). This is evidence that butyrate is used as an energy source and can be growth stimulatory. To further address source in glucose/pyruvate deficient medium. This could this possibility, preliminary metabolic labelling studies were explain why, under these conditions, butyrate is not growth conducted using S/RG/C2 cells. We found that [ 14 C]butyrate inhibitory. It is actively metabolized thus intracellular butyrate accumulation may be reduced. is more rapidly metabolized (producing more 14 CO 2 ) in An important conclusion from our studies is that the response conditions) and, hence, its potential protective effects against colorectal cancer. of colonic epithelial cells to butyrate may depend in part on To our knowledge, this is the first report of apoptosis in the other energy sources available to the epithelium. In response to energy deprivation (glucose deprivation) in human conditions of low energy availability, butyrate could be growth colonic epithelial cell cultures. The apoptotic pathway in stimulatory and/or trophic, but in the presence of high levels response to energy deprivation in these cells must be via a of alternative energy sources such as glucose, butyrate could p53 independent pathway since both the S/RG/C2 and HT29 switch from a growth stimulator to a growth inhibitor and/or cells used in these studies lacked wild-type p53 (30) . Our an inducer of apoptosis. In view of the metabolic relationship results also show that the response of cells to butyrate, i.e. between butyrate and glucose observed in colonocytes (25) , it whether growth inhibitory or stimulatory, may depend on the may well be that the 'switch to the oxidation' of butyrate in availability of other energy sources and that, in glucoseglucose-deprived culture may be a compensatory mechanism depleted conditions, butyrate at low concentration can be in response to a reduction in energy pools.
growth stimulatory to colon epithelial cells in culture. These A remaining important question is whether colonic tumour observations may, in part, provide an explanation for the cells are more sensitive to the growth inhibitory effects of apparent opposite effects of butyrate on proliferation reported butyrate than normal colon cells. The differential sensitivity in vivo and in vitro. The present study also provides a model of cells at different stages of tumour progression being potensystem to further our understanding of the possible importance tially very important in determining the effectiveness of a of total energy availability, and utilization, whether through potential chemopreventive agent (21) . Most previous studies luminal dietary factors or through the vasculature, and how have compared normal cells in vivo, with tumour cell lines this may influence colonic carcinogenesis. in vitro. Long-term normal adult human colonic epithelial cells have proved difficult to culture (26) and, therefore, it has been
